Menu
Not yet recruiting NCT07674797

Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)

No phase Interventional Oncologic Palliative Care Remote Monitoring Electronic Assessments

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Questionnaire and Physical Exam.
Who it may be relevant to
Registry conditions: Oncologic, Palliative Care, Remote Monitoring, Electronic Assessments. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

To examine how we can provide supportive care for patients with advanced cancer better tailored to their needs

Detailed description

Primary Objectives Objective 1: To compare the impact of timely SPC referral and enhanced usual care (i.e., selective referral) on the proportion of participants with an outpatient SPC consultation at (a) 12 weeks (primary outcome) and (b) 24 weeks post-initial screening.

Interventions

  • Other Questionnaire and Physical Exam
    Patient will complete questionnaires and physical exams

Primary outcome measures

  • Self Report Questionnaire [Time frame: Through study completion; an average of 1 year]

Eligibility criteria

Eligibility Criteria

  • Age ≥ 18
  • Outpatients who are within 12 weeks of diagnosis of metastatic solid tumors and seen by one of the participating medical oncologists
  • Eastern Cooperative Oncology Group Performance Status 0.2
  • Able to speak English or Spanish

Exclusion criteria

. Cognitive impairment in the opinion of the oncologist necessitating need for a surrogate decision making.

  • Previously seen by SPC team at UT MD Anderson

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • MD Anderson Cancer Center — Houston

Identifiers

NCT: NCT07674797 · 2026-0421 · NCI-2026-04860

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗